Physician profile
Mario Leandre
NPI 1942694559
$2,247.30
in general payments reported to CMS, 2019-2025
8 companies · $112 in 2025
The $112 reported for 2025 was more than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $48.53 · 2022: $275 · 2023: $290 · 2024: $1,522 · 2025: $112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $998 · Food and Beverage: $925.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $998.24 |
| Food and Beverage | $925.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,318.10 | 2024 | Mitraclip |
| Boston Scientific Corporation | $334.86 | 2022-2025 | Watchman Access System, Watchman Flx |
| Abiomed | $249.76 | 2022-2024 | Impella |
| Medtronic, INC. | $178.36 | 2024-2025 | Cardioblate Cryoflex, Avalus, Vitalflow Console |
| Haemonetics Corporation | $92.58 | 2022 | |
| Covidien LP | $48.53 | 2020 | |
| Edwards Lifesciences Corporation | $12.71 | 2022 | |
| Terumo Medical Corporation | $12.40 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mario Leandre listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.